BP Directors, LP's Form 4 filing
Actuate Therapeutics, Inc. (ACTU) · filed Jun 30, 2025
- Accession no.
- 0001104659-25-063993
- Filed
- Jun 30, 2025, 1:03 PM ET
- Trade date
- Jun 27, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $500.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BP Directors, LPCIK 0001813311 | Director, 10% Owner |
| Bios Clinical Opportunity Fund, LPCIK 0001988639 | Director, 10% Owner |
| Bios Equity COF, LPCIK 0002000747 | Director, 10% Owner |
| Bios 2024 Co-Invest, LPCIK 0002028708 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | Common Stock | PPurchaseAcquired | +71,428 | $7.00 | +$499,996 | 196,428 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | Common Stock | PPurchaseAcquired | +71,428 | $0.00 | $0 | 71,428 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.